Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind, Randomized, Sham-controlled Study of Closed-loop Repetitive Transcranial Magnet Stimulation (rTMS) for the Short-term Prevention of Migraine

NCT06735768 is registered in ClinicalTrials.gov with Brightmind.AI as lead sponsor.

NCT NCT06735768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06735768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind, Randomized, Sham-controlled Study of Closed-loop Repetitive Transcranial Magnet Stimulation (rTMS) for the Short-term Prevention of Migraine
Lead sponsor
Brightmind.AI
Phase
Not applicable
Overall status
Recruiting
Start date
December 9, 2024
Completion date
August 31, 2025
Enrollment
88 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine disorders